市場調查報告書
商品編碼
1261512
2022-2028 年全球光學成像市場規模,份額,行業趨勢分析報告,按產品,最終用戶,技術,應用,治療領域,地區展望和預測Global Optical Imaging Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Technique, By Application, By Therapeutic Area, By Regional Outlook and Forecast, 2022 - 2028 |
到 2028 年,光學成像市場規模預計將達到 31 億美元,預測期內復合年增長率為 13.1%。
例如,拉曼光譜檢查光的非彈性散射,而熒光和磷光依賴於吸收後的發射。 光學成像提供了納米 (nm) 範圍內非常高的空間分辨率的潛力,從而產生實時和定量數據。 此外,可以照亮組織並從身體深處收集發光的光纖內窺鏡探頭可能有助於解決這個問題。 此外,由於近紅外光在軟組織中的散射和吸收比可見光少,因此近紅外成像可用於觀察數厘米的深度。
熒光成像用於先進的熒光介導斷層掃描/類似 microCT 的混合斷層掃描系統,為藥物研究中的傳統 PET 分析提供了一種有用的替代方法。 廣角 NIR 熒光分子內窺鏡和其他設備設計正在推廣,以促進食管病變和結直腸腺瘤的早期檢測。
COVID-19 影響分析
COVID-19 大流行使保持社交距離對醫生和其他醫護人員來說更加重要。 由於 COVID-19,幾個成像部門的光學成像病例數量正在迅速減少。 光學成像病例的減少將對所有臨床環境的短期和長期經濟穩定性產生嚴重影響。 由於 COVID-19,全球對光學成像設備的需求顯著減少。 光學影像設備需求的大幅下降主要是由於疫情導致各國取消擇期手術以及關閉醫院和診斷機構。 預計門診人數下降也將在整個預測期內抑制市場擴張。
市場增長因素
技術進步
生物醫學工程師正在政府資助下開發一種最先進的光學成像方法,該方法可以識別鞏膜中膠原纖維的結構變化。 該技術使用計算機模型將鞏膜蛋白的特定改變與早發性青光眼聯繫起來。 這項新測試可實現早期治療和持續的非侵入性治療反應監測,以保護視力。 工程師們正在開髮用於關鍵實時成像的光學成像設備,以檢測大腦中的血流和氧氣使用等代謝過程。 這支持了本地市場的增長。
覆蓋面的擴大
可見光,近紅外光和近紫外光的拉曼散射是拉曼光譜的基礎。 物質的分子振動與激光相互作用引起能量變化,從而揭示物質的化學成分。 它用於鑑定化合物,晶體和物質的結構分析。 拉曼氣體分析儀在外科手術中用於監測麻醉氣體混合物。 光學成像技術在各種疾病診斷和治療中的廣泛應用有望推動光學成像市場的增長。
市場約束
醫護人員短缺
衛生工作者對於衛生系統的運作至關重要。 它的可用性,可及性,可接受性和質量都是擴大醫療保健覆蓋面和實現享有最大可能健康水平的權利的決定因素。 世界衛生組織預測,到 2030 年將有 1000 萬衛生工作者短缺,其中大部分在低收入和中等收入國家。 所有社會經濟層面的政府都在不同程度上面臨培訓,僱用,部署,保留和履行其勞動力的挑戰。 這些因素正在推動該地區市場的擴張。
產品概覽
根據產品,光學成像市場分為成像系統,相機,軟件,照明系統,鏡頭及其他。 成像系統部分在光學成像市場佔據主導地位,2021 年收入份額最大。 這是由於它在癌症,眼科和其他領域的廣泛應用。 這些系統經常被使用,因為它們提供實時微米級分辨率,一維深度,二維橫截面和 3D 體積圖像,成像深度高達幾毫米,並且沒有有害輻射。
應用展望
根據應用,光學成像市場分為病理成像和術中成像。 術中成像部分在 2021 年的光學成像市場中佔據了相當大的收入份額。 這是因為術中成像和監測使醫生能夠獲得生理信息來指導手術,並從長遠來看改善恢復時間和生活質量。 在這種情況下,光學成像提供了一種高度實用,便攜,負擔得起的實時解決方案,該解決方案對多種感興趣的生理因素敏感。
最終用戶視角
按最終用戶劃分,光學成像市場分為醫院和診所,研究實驗室以及製藥和生物技術公司。 實驗室部門在 2021 年的光學成像市場中佔據了顯著的收入份額。 這是由於越來越重視研發工作,以創造各種光學成像的新應用。 隨著越來越多的光學成像技術被用於臨床前研究和藥物發現程序,市場有望得到發展。 生命科學行業研發活動的增加將在預測期內進一步推動該領域的擴張。
治療領域展望
根據治療領域,光學成像市場分為眼科,腫瘤科,心髒病科,皮膚科,神經科等。 2021 年,腫瘤科在光學成像市場的收入份額最高。 這是因為通過使用光學方法檢查組織,可以檢測組織的生化和結構方面。 它還具有靈敏度高,成本低,分辨率高等優點。 該技術也越來越受歡迎,因為它有助於及早發現癌症並且是非侵入性的。 隨著癌症變得越來越普遍,有助於早期癌症檢測的光學成像將推動這一領域的增長飛速發展。
技術展望
根據技術,光學成像市場分為光學相干層析成像,近紅外光譜,高光譜成像和光聲層析成像。 在2021年的光學成像市場中,光聲層析成像領域取得了令人矚目的增長速度。 這是因為光聲斷層掃描是一種混合的非侵入性成像技術,可同時適應分子成像和功能成像。 此外,隨著對非侵入性技術的需求不斷增加,光學層析成像技術在生物醫學成像方面優於傳統的光學成像競爭對手。 所有這些原因預計將有助於預測期內該行業的擴張。
區域展望
按地區劃分,分析了北美,歐洲,亞太地區和 LAMEA 的光學成像市場。 北美地區將在 2021 年佔據光學成像市場的最高收入份額。 這是由於政府通過提供合格的人力資源,強大的研究基礎設施,投資和資金來支持該領域的技術進步。 此外,該領域技術改進項目的快速採用有望進一步加速市場擴張。
市場進入者採取的主要策略是收購。 根據基數矩陣中的分析,Abbott Laboratories 和 Leica Microsystems GmbH (Danaher Corporation) 是光學成像市場的領導者。 Carl Zeiss AG 和 Canon Inc.(佳能醫療系統公司)等公司是光學成像市場的主要創新者。
The Global Optical Imaging Market size is expected to reach $3.1 billion by 2028, rising at a market growth of 13.1% CAGR during the forecast period.
Optical imaging technologies have great potential for the healthcare sector in terms of improving illness detection, prevention, and treatment. Due to factors such as emerging application areas, increased consumer demand for noninvasive technologies, and an increase in chronic diseases and eye conditions, the market for optical imaging systems is growing. Due to the growing emphasis on early illness diagnosis and the desire for efficient solutions, optical imaging system sales are anticipated to rise quickly.
The science of optical imaging, which employs light to examine cellular and molecular activity in live organisms, is non-invasive and non-ionizing. Electromagnetic radiation, including visible light, contains wave and particle characteristics. Depending on the makeup of the tissue, photons may be absorbed, reflected, or dispersed as they pass through it. Various optical imaging techniques examine these interactions to produce distinctive spectral fingerprints that might provide information about the molecular structure of the target tissue.
For instance, Raman spectroscopy examines the inelastic scattering of light, whereas fluorescence and phosphorescence rely on the emission of light after its absorption. Optical imaging offers a very high spatial resolution in the nanometre (nm) range and may give real-time and quantitative data. Fiberoptic endoscopic probes, which enable tissue lighting and collecting the emitted light from deep inside the body, may partially help overcome this. Moreover, soft tissues exhibit less scattering and absorption in the electromagnetic spectrum's near-infrared (NIR) region than in the visible band, allowing the probing depth to be raised to a few centimeters when utilizing NIR optical imaging.
Fluorescence imaging is used in hybrid tomographic systems like advanced fluorescence-mediated tomography/micro-CT, which provides a useful alternative to traditional PET analysis in drug research. Wide-field NIR fluorescence molecular endoscopy and other device designs have been promoted for enhancing the early detection of esophageal lesions and colorectal adenomas.
COVID-19 Impact Analysis
The COVID-19 pandemic made it more important for physicians and other healthcare workers to maintain social distancing. Due to COVID-19, optical imaging case volumes have rapidly decreased in several imaging and diagnostic departments. The fall in optical imaging cases seriously impacts the short- and long-term economic stability of all practice settings. The need for optical imaging devices has significantly decreased globally because of COVID-19. The large drop in demand for optical imaging equipment is primarily attributable to canceling of elective operations and the closing of hospitals and diagnostic facilities in various nations due to the pandemic. Also, the decline in outpatient visits is anticipated to restrain market expansion throughout the projection period.
Market Growth Factors
Technological progress
A cutting-edge optical imaging method that can identify changes in the organization of the collagen fibers in the eye sclera is being developed by biomedical engineers with funding from the government. The technique uses a computer model that links certain alterations in sclera proteins to early-onset glaucoma. The new test will allow for early treatment that preserves eyesight and ongoing non-invasive treatment response monitoring. Engineers are developing an optical imaging device for crucial real-time imaging that detects brain blood flow and metabolic processes, including oxygen use. This supports the growth of the regional market.
Expanding the spheres of applicability
Raman scattering of visible, near-infrared, or near-ultraviolet light provides the basis for Raman spectroscopy. The material's molecular vibrations interact with the laser light, causing energy changes that disclose the substance's chemical composition. Uses include the identification of chemical compounds and the crystal and material structure. Raman gas analyzers are used in surgery to monitor the anesthetic gas mixture. The wide usage of optical imaging techniques for diagnosing and treating various diseases is expected to boost the optical imaging market growth.
Market Restraining Factors
Lack of healthcare workers
Health workers are essential to the operation of health systems. Their availability, accessibility, acceptability, and quality are all determinants of expanding healthcare coverage and attaining the right to the enjoyment of the greatest possible level of health. By 2030, the WHO predicts a ten-million-person shortage in the health workforce, mostly in low- and lower-middle-income nations. To varied degrees, governments at all socioeconomic levels have challenges with their workforce's training, employment, deployment, retention, and performance. These elements are assisting the market's expansion in the region.
Product Outlook
Based on product, the optical imaging market is segmented into imaging systems, camera, software, illuminating systems and lenses & others. The imaging systems segment dominated the optical imaging market with maximum revenue share in in 2021. This is due to its extensive use in cancer, ophthalmology, and other fields. These systems are frequently used because they provide real-time, micron-level resolution, 1D depth, 2D cross-sectional, and 3D volumetric pictures at imaging depths of up to a few millimeters and no harmful radiation.
Application Outlook
On the basis of application, the optical imaging market is divided into pathological imaging and intraoperative imaging. The intraoperative imaging segment garnered a substantial revenue share in the optical imaging market in 2021. This is owing to intraoperative imaging and monitoring, which gives doctors access to physiological information that may be used to guide surgery and enhance recovery time and quality of life in the long run. Optical imaging in this context provides extremely practical, portable, affordable, and real-time solutions sensitive to several physiological factors of interest.
End User Outlook
By end user, the optical imaging market is classified into hospitals & clinics, research laboratories and pharmaceutical & biotechnology companies. The research laboratories segment recorded a prominent revenue share in the optical imaging market in 2021. This is due to the increased emphasis on R&D operations to create different new applications of optical imaging. The market is expected to develop as more optical imaging techniques are used in preclinical research and drug discovery procedures. The increasing R&D efforts in the life sciences industry will further boost the segment's expansion in the forecasted period.
Therapeutic Area Outlook
Based on the therapeutic area, the optical imaging market is bifurcated into ophthalmology, oncology, cardiology, dermatology, neurology and others. The oncology segment registered the highest revenue share in the optical imaging market in 2021. This is because the optical way of examining tissues can detect both the biochemical and structural aspects of the tissue. It also has the benefits of high sensitivity, low cost, and high resolution. The technique is also gaining popularity since it aids in the early identification of cancer and is non-invasive. As cancer is becoming more common, along with the benefits optical imaging provides in early cancer detection, the segment's growth will surge.
Technique Outlook
On the basis of technique, the optical imaging market is divided into optical coherence tomography, near infrared spectroscopy, hyperspectral imaging and photoacoustic tomography. The photoacoustic tomography segment garnered a remarkable growth rate in the optical imaging market in 2021. This is because photoacoustic tomography is a hybrid noninvasive imaging technique for both molecular and functional imaging. In addition, the demand for noninvasive technology is growing, and optical tomography performs better in biomedical imaging than its traditional optical imaging competitors. All these reasons are anticipated to contribute to the segment's expansion in the projected period.
Regional Outlook
Region-wise, the optical imaging market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generated the highest revenue share in the optical imaging market in 2021. This is due to the availability of qualified people, a strong research infrastructure, and government attempts to support technical improvement in the sector by providing investments and money. Moreover, quicker adoption of technologically improved items in the area is anticipated to accelerate market expansion further.
The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Abbott Laboratories and Leica Microsystems GmbH (Danaher Corporation) are the forerunners in the Optical Imaging Market. Companies such as Carl Zeiss AG and Canon, Inc. (Canon Medical Systems Corporation) are some of the key innovators in Optical Imaging Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss AG, Leica Microsystems GmbH (Danaher Corporation), Abbott Laboratories, Canon, Inc. (Canon Medical Systems Corporation), PerkinElmer, Inc., Topcon Corporation, Hamamatsu Photonics K.K., Koninklijke Philips N.V., Heidelberg Engineering, Inc. and Visionix Ltd.
Recent Strategies Deployed in Optical Imaging Market
Partnerships, Collaborations and Agreements:
Jan-2023: Canon came into partnership with ScImage, Inc., a Cloud-native image management company offering services to the healthcare industry. This partnership would enable Canon to leverage Sclmage cloud-driven image management and PACS solutions in enhancing Canon's outreach in hemodynamics empowering it to better serve its customers.
May-2022: Visionix partnered with Right MFG. Co., Ltd., an innovative medical devices manufacturer, for making growth in their businesses. With this partnership, Right MFG's expertise in offering advanced medical devices would enable Visionix to develop and deliver a product range for eyecare businesses facilitating eye care professionals.
Mar-2022: Hamamatsu Photonics K.K announced its collaboration with Proscia, a digital and computational pathology solutions provider, to enhance digital pathology embracement. Through this partnership, Hamamatsu's NanoZoomer® series of whole slide scanners for digital transformation would be combined with Proscia's Concentriq® platform to create an open ecosystem for raising the digital pathology embracement ratio in the market.
Aug-2020: Canon signed a partnership with Zebra Medical Vision, a computer vision startup serving healthcare, to broaden its AI offerings. With this partnership, Zebra Medical Vision's services into the Modality domain would empower Canon to deliver its AI1™ automated imaging analysis solutions to facilitate U.S. clinicians in the delivery of faster, and required diagnoses to patients.
Product Launches and Product Expansions:
Nov-2021: Koninklijke Philips N.V. unveiled AI-based MR suite of smart diagnostic systems. The MR portfolio would incorporate smart integrated solutions such as MR 7700 3.0T system, developed to accelerate MR examination, smooth workflow, improved diagnostic quality, and provide aid in the optimization of radiology operations.
Jul-2021: Canon announced the launch of Xephilio OCT-S1, an advanced Wide -field Swept Source Optical Coherence Tomography. Xephilio OCT-S1 would enable customers to capture high-resolution pictures of up to 23 x 20 mm in just one-time scanning. Additionally, it would allow users to use its wide-angle OCT Imaging Angiography feature and delivers OCTA images with enhanced visibility.
Apr-2021: Abbott unveiled an AI-powered coronary OCT imaging system in Europe. The AI-powered coronary OCT imaging system, developed by integrating imaging technology with AI and would offer surgeons an automated system useful in cardiac procedures, providing information quickly in the course of the placement of coronary stents.
Acquisitions and Mergers:
Jan-2023: Carl Zeiss completed the acquisition of Lenso, an optical 3D metrology manufacturer, to make developments in Zeiss's Industrial Quality and Research division. Through this acquisition, Carl Zeiss's industrial quality solutions would be utilized for Zeiss's Industrial Quality & Research division expansion across Poland.
Oct-2022: Carl Zeiss acquired GOM Metrology, to serve the UK customer base by providing better tactile and optical technology suite offerings. With this acquisition, GOM Metrology would bring its GOM software, machines, automated 3D coordinate computing technology, and 3D testing to strengthen Zeiss Industrial Quality Solutions' portfolio.
Oct-2021: Carl Zeiss took over Capture 3D, a 3D Scanning technology, photogrammetry, and automated inspection solutions provider, to make advancements in optical digitization systems. Through this acquisition, Capture 3D's capabilities in supplying required data intelligence for better decision-making would enable Zeiss to better support its customers by providing them the advanced measurement solutions.
Oct-2021: Canon acquired Redlen Technologies, developer and manufacturer of high-resolution CZT semiconductor detectors. Through this acquisition, Canon would make developments in its medical systems business by getting advanced radiation detection and imaging technology, utilized in CZT semiconductor detector modules, through Redlen Technologies to develop advanced PCCT systems.
Jul-2021: Topcon Corporation completed the acquisition of VISIA Imaging S.r.l, an Italian-based ophthalmic device manufacturing company. Through this acquisition, VISIA's expertise in manufacturing anterior segment evaluation hardware and software would be leveraged by Topcon to intensify Topcon's manufacturing and innovation capabilities in anterior segment devices and software that would advance Topcon's fundus imaging devices suite.
Market Segments covered in the Report:
By Product
By End User
By Technique
By Application
By Therapeutic Area
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures